Structure |
Chemical Name |
CAS |
MF |
 |
Febuxostat Impurity 67 |
|
|
 |
Riociguat IMpurtiy A |
|
|
 |
Peramivir Impurity C |
|
|
 |
Lincomycin sulfoxide Impurity 6 |
|
|
 |
Metronidazole IMpurity 5 |
|
|
 |
Sulpiride Impurity 5 |
|
|
 |
methyl 3-(4-(3-(ethylamino)-2-hydroxypropoxy)phenyl)propanoate hydrochloride |
|
C15H24ClNO4 |
 |
Tacrolimus Impurity F |
|
|
 |
Cefminox Impurity E |
|
|
 |
Oxaliplatin impurity |
|
|
 |
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
 |
Alogliptin Impurity D |
1926163-25-8 |
C61H86N16O13 |
 |
Moxifloxacin Impurities |
|
|
 |
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
 |
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
 |
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
![L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1)](../cas/20211123/gif/1194550-65-6.gif) |
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
 |
Alogliptin Related Compound 23 |
1618644-29-3 |
C20H13ClN4O2 |
 |
Etoricoxib Impurity 14 |
|
|
 |
Riociguat Impurtiy 3 |
|
|
 |
Trelagliptin Impurity 2 |
|
|
 |
Chlorhexidine Impurity B |
1308292-89-8 |
C16H26ClN9O |
 |
Dapoxetine Impurity D |
|
|
 |
Eltrombopag Impurity 5 |
|
|
 |
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
 |
Lidocaine Impurity |
35891-84-0 |
C11H17ClN2O |
 |
Pramipexole Impurity J |
|
|
 |
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
 |
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
![1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide](../cas/20180703/gif/503612-76-8.gif) |
1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
503612-76-8 |
C24H23N5O4 |
![8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one](../cas/20180703/gif/869478-13-7.gif) |
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
![1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](../cas/20180703/gif/743460-48-2.gif) |
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
 |
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
 |
Silodosin impurity A |
|
|
 |
cefditoren △-3 isomer |
|
|
 |
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
 |
Ofloxacin/Levofloxacin Impurity E |
|
|
![(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](../cas/20180703/gif/1026952-91-9.gif) |
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
 |
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
 |
Tofacitinib Impurity L |
|
|
 |
1-chloro-3-(dimethoxymethyl)benzene |
3395-80-0 |
C9H11ClO2 |
 |
N-(3-bromo-4-oxocyclohexyl)acetamide |
687639-03-8 |
C8H12BrNO2 |
 |
methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C44H51N9O4 |
 |
Alvimopan Impurity 5 |
|
|
 |
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
 |
Ivabradine Impurity 15 |
1132667-04-9 |
C12H17NO2 |
 |
Sofosbuvir Impurity27 |
|
|
 |
Isavuconazole Impurity 12 |
|
|
 |
Tacrolimus Impurity 3 |
161861-10-5 |
C45H71NO13 |
 |
Aprepitant EP Impurity C |
2208275-99-2 |
C29H25F7N4O3 |
 |
Bisoprolol EP Impurity J |
1797024-50-0 |
C15H24O5 |
 |
Ceftriaxone Impurity |
79221-95-7 |
C18H18N8O8S3 |
 |
Betaxolol EP Impurity E |
1329613-85-5 |
C18H31NO3 |
 |
Tulobuterol Impurity |
34356-83-7 |
C8H5Br2ClO |
 |
Olaparib Impurity A |
|
|
 |
Dapoxetine Impurity 2 |
|
|
 |
Voriconazole Impurity 5 |
|
|
 |
tetrahydrofuran-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate |
1404453-75-3 |
C17H22O4 |
 |
Lamivudine impurity 5 |
|
|
 |
Clopidogrel Impurity 2 |
|
C15H14ClNO2S |
 |
Mirabegron Impurity 6 |
2762802-64-0 |
C10H11ClN4O3S2 |
 |
Pitavastatin Impurity 3 |
|
|
 |
Solifenacin EP Impurity D |
|
|
 |
Cephalexin Impurity 2 |
|
C16H17N3O4S |
 |
Cefuroxime Impurity 3 |
|
C16H16N4O8S |
 |
Vonoprazan Impurity 11 |
|
|
 |
Atracurium Impurity A |
|
|
 |
Erlotinib Imp.14 |
|
|
 |
Sorafenib related compound 12 |
284461-74-1 |
C20H14ClF3N4O3 |
 |
Apremilast Impurity 10 |
1809170-71-5 |
C22H26N2O8S |
 |
(1R,3S)-Solifenacin Succinate |
774517-20-3 |
C23H26N2O2 |
 |
Dacpomycin Impurity 2 |
|
|
 |
Nicorandil Impurity 3 |
|
|
 |
Tacrolimus Impurity A |
|
|
![1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)-](../cas/20180703/gif/135729-73-6.gif) |
1H-Benz[de]isoquinolin-1-one,2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,(3aR)- |
135729-73-6 |
C19H24N2O |
 |
Afatinib Impurity 16 |
|
|
 |
Mirabegron Impurity 19 |
|
|
 |
(Z)-Mutagenic Impurity of Tenofovir Disoproxil |
1464851-21-5 |
C8H9N5 |
 |
Moxifloxacin impurity (20) |
|
|
 |
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
 |
Bazedoxifene impurity |
|
|
 |
Tamsulosin impurity |
|
C20H28N2O5S |
 |
Clarithromycin (9Z)-Oxime |
127253-05-8 |
C38H70N2O13 |
 |
N-Desmethyl Clarithromycin (9E)-Oxime |
127182-43-8 |
C37H68N2O13 |
 |
Ticagrelor Impurity 24 |
1482484-92-3 |
C7H11N3O2S |
 |
Moxifloxacin Impurity |
1797982-51-4 |
C16H16FNO5 |
 |
sofosBuvir impurity 1 |
|
|
 |
2-(3-cyano-4-isopropoxyphenyl)-4-methylthiazole-5-carboxylic acid |
144060-52-6 |
C15H14N2O3S |
 |
Alogliptin Related Compound 26 |
865759-10-0 |
C25H24N6O2 |
 |
R-Tirofiban |
158808-86-7 |
C22H36N2O5S |
 |
Canagliflozin Impurity 20 |
|
|
 |
Canagliflozin Impurity 6 |
|
|
 |
Carfilzomib Impurity 6 |
|
|
 |
Daclatasvir Impurity 5 (SRSS-Isomer) |
1009117-28-5 |
C40H50N8O6 |
 |
Dolutegravir Impurity 7 |
2244161-71-3 |
C20H21N3O5 |
 |
Istradefylline Impurity F |
|
|
 |
Linagliptin Impurity 22 |
|
|
 |
Nintedanib impurity G |
894783-61-0 |
C30H31N5O4 |
![3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine)](../cas/20211123/gif/1010818-93-5.gif) |
3,3′-[(2-methylbenzene-1,3-diyl)bis(oxy)]bis(N-methyl- 3-phenylpropan-1-amine) |
1010818-93-5 |
C27H34N2O2 |
 |
Febuxostat impurity 36 |
1805770-40-4 |
C12H12N2O |